About the Cancer Metabolomics Session
Metabolomics is the worldwide assessment and confirmation of endogenous small-molecule biochemicals (metabolites) within a biologic system. It is one of the "omic" sciences in systems biology. The metabolism of cancer cells is dysregulated to meet the demands of uncontrolled proliferation. This rewiring of cellular metabolism produces distinct metabolic phenotypes that can be exploited for earlier cancer detection, patient selection techniques for clinical trials, and/or treatment response biomarkers. Metabolomics aims to use cancer’s metabolic signature to estimate disease risk, detect cancer earlier, diagnose particular disease subtypes, and track treatment outcomes. In principle, metabolomics could aid in the rational selection of targeted medicines to meet cancer’s metabolic requirements.
- Cancer Cell Metabolism
- Cancer Therapies That Target Metabolism
- Systemic Metabolic Effects of Cancer
- Clinical Implementation of Metabolomics
- Biomarkers for Cancer
Topics Covered in Cancer Metabolomics
Metabolic Reprogramming
Oncometabolites
Mass Spectrometry
NMR Spectroscopy
Stable Isotope Tracing
Metabolic Biomarkers
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Metabolomics Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Metabolomics work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Metabolomics research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Metabolomics track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Metabolomics Conference 2027 — FAQs
What is the Cancer Metabolomics track at CIOC 2027?
The Cancer Metabolomics track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Metabolomics. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Metabolomics sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Metabolomics are all welcome — whether presenting or attending.
Can I present my research in the Cancer Metabolomics track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Metabolomics sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Metabolomics track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
